ADVFN US – Market Content Editor
-
CoreWeave shares rise after closing $8.5B financing facility
CoreWeave (NASDAQ:CRWV) shares gained about 6% on Tuesday after the company announced the completion of an $8.5 billion delayed draw term loan facility, alongside broader strength across technology stocks. The financing received investment-grade ratings of A3 from Moody’s and A (low) from DBRS, marking what the company described as the first investment-grade-rated financing tied to…
-
Momentus deploys Vigoride 7 spacecraft carrying 10 payloads on SpaceX mission
Momentus Inc. (NASDAQ:MNTS) announced that its Vigoride 7 Orbital Service Vehicle has been successfully deployed after launching aboard SpaceX’s Transporter-16 mission on March 30. The spacecraft separated from the Falcon 9 rocket at an altitude of roughly 500 kilometers. Following deployment, the vehicle’s 1.6-kilowatt solar arrays successfully unfolded and are now supplying power to the…
-
NVIDIA commits $2 billion investment in Marvell to expand AI infrastructure collaboration
NVIDIA Corporation (NASDAQ:NVDA) announced a $2 billion investment in Marvell Technology Inc. (NASDAQ:MRVL) as part of a strategic partnership aimed at strengthening NVIDIA’s artificial intelligence infrastructure ecosystem through its NVLink Fusion technology. The collaboration will integrate Marvell into NVIDIA’s AI factory and AI-RAN ecosystem using NVLink Fusion, a rack-scale platform designed to help customers build…
-
Opera introduces MCP Connector for Neon browser to enable AI integrations
Opera (NASDAQ:OPRA) has unveiled a new MCP Connector for its Opera Neon browser, allowing external artificial intelligence tools to connect directly to the browser and perform actions within a user’s active browsing session. According to the Norwegian browser developer, the connector allows AI platforms such as Claude, ChatGPT, Lovable, n8n, and OpenClaw to access real-time…
-
Alaska Airlines unveils business class suites for new Europe and Asia routes
Alaska Airlines (NYSE:ALK) has introduced a new International Business Class offering aboard its Boeing 787-9 Dreamliners as the carrier expands service to destinations in Europe and Asia this spring. The upgraded cabin features fully lie-flat suites equipped with privacy doors, direct aisle access, and 18-inch HD entertainment screens. Travelers will also be served multi-course meals…
-
Agios shares jump as FDA discussions advance mitapivat approval pathway
Agios Pharmaceuticals (NASDAQ:AGIO) shares climbed about 12% on Tuesday after the company reported progress toward a potential accelerated U.S. approval for its drug candidate mitapivat in treating sickle cell disease following a pre-supplemental New Drug Application meeting with the U.S. Food and Drug Administration. During the discussions, the FDA advised Agios to submit a proposal…
-
Cintas secures $2 billion revolving credit facility extending to 2031
Cintas Corporation (NASDAQ:CTAS) announced that its wholly owned subsidiary, Cintas Corporation No. 2, entered into a new $2 billion revolving credit facility on March 27, 2026. The agreement includes a letter of credit sub-facility of up to $300 million and a swing line sub-facility of up to $150 million. KeyBank National Association is serving as…
-
Scholar Rock shares jump after FDA resubmission for SMA therapy
Scholar Rock (NASDAQ:SRRK) shares climbed about 12% on Tuesday after the company announced it had resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration for apitegromab, a therapy aimed at treating children and adults with spinal muscular atrophy (SMA). The updated filing includes Catalent Indiana LLC, a facility owned by Novo…
-
Alkermes shares jump 13% after Lilly announces sleep-disorder acquisition
Shares of Alkermes (NASDAQ:ALKS) climbed about 13% on Tuesday after Eli Lilly (NYSE:LLY) revealed plans to acquire Centessa Pharmaceuticals (NASDAQ:CNTA), a biotechnology company developing therapies for sleep-related disorders. Under the agreement, Lilly will purchase all outstanding and to-be-issued Centessa shares for $38.00 in cash per share, along with a non-transferable contingent value right (CVR) that…
-
Xtant Medical shares drop nearly 5% as weak 2026 outlook overshadows Q4 beat
Xtant Medical Holdings (AMEX:XTNT) shares fell about 4.7% in pre-market trading Tuesday after the company reported fourth-quarter results that topped expectations but issued 2026 revenue guidance well below Wall Street forecasts. For the quarter, the medical technology firm posted adjusted earnings per share of $0.00, outperforming the analyst estimate of -$0.01. Revenue came in at…